Arizona State Retirement System Rubius Therapeutics, Inc. Transaction History

Arizona State Retirement System

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 28, 2022	SELL	$0.79 - $5.98 $8,635 - $65,367	-10,931 Closed	0 $0
Q1 2022 May 04, 2022	BUY	$4.25 - $10.4 $246 - $603	58 Added 0.53%	10,931 $60,000
Q4 2021 Feb 04, 2022	SELL	$9.68 - $17.74 $726 - $1,330	-75 Reduced 0.69%	10,873 $105,000
Q3 2021 Nov 12, 2021	BUY	$17.6 - $25.91 $17,916 - $26,376	1,018 Added 10.25%	10,948 $196,000
Q2 2021 Aug 02, 2021	BUY	$22.26 - $28.43 $11,285 - $14,414	507 Added 5.38%	9,930 $242,000
Q1 2021 May 06, 2021	BUY	$8.02 - $32.01 $75,572 - $301,630	9,423 New	9,423 $250,000

325

Ticker RUBY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 90,357,000
Description
Rubius Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of red cell therapeutics (RCTs) for the treatment of patients with severe diseases. The company is developing RTX-240 and RTX-224 for the treatment of solid tumors cancer; and RTX-aAPC to treat cancers. It is also developing RTX-321 for the treatmen...

Get notified when there are updates to the investment portfolio of Arizona State Retirement System, based on Form 13F filings with the SEC.

Stay updated on Arizona State Retirement System with notifications on news.